本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cellectar Biosciences Inc.

2.70
-0.2000-6.90%
盤後2.700.00000.00%19:12 EDT
成交量:3.15萬
成交額:8.81萬
市值:1,144.84萬
市盈率:-0.32
高:2.87
開:2.87
低:2.70
收:2.90
52周最高:20.59
52周最低:2.45
股本:424.01萬
流通股本:405.90萬
量比:1.17
換手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):-8.3544
每股收益(LYR):-8.3544
淨資產收益率:-170.27%
總資產收益率:-71.01%
市淨率:1.43
市盈率(LYR):-0.32

資料載入中...

2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/11

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/11

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]